Attached files

file filename
10-K - FORM 10-K - CUMBERLAND PHARMACEUTICALS INCg26446e10vk.htm
EX-31.2 - EX-31.2 - CUMBERLAND PHARMACEUTICALS INCg26446exv31w2.htm
EX-31.1 - EX-31.1 - CUMBERLAND PHARMACEUTICALS INCg26446exv31w1.htm
EX-23.1 - EX-23.1 - CUMBERLAND PHARMACEUTICALS INCg26446exv23w1.htm
EX-10.13 - EX-10.13 - CUMBERLAND PHARMACEUTICALS INCg26446exv10w13.htm
EX-10.12 - EX-10.12 - CUMBERLAND PHARMACEUTICALS INCg26446exv10w12.htm
EX-10.26 - EX-10.26 - CUMBERLAND PHARMACEUTICALS INCg26446exv10w26.htm
EX-10.15 - EX-10.15 - CUMBERLAND PHARMACEUTICALS INCg26446exv10w15.htm
EX-10.11 - EX-10.11 - CUMBERLAND PHARMACEUTICALS INCg26446exv10w11.htm
Exhibit 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Cumberland Pharmaceuticals Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, A.J. Kazimi, Chief Executive Officer, and David L. Lowrance, Vice President and Chief Financial Officer, of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. section 1350), that, based on my knowledge:
 
1.   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ A. J. Kazimi
A.J. Kazimi
Chief Executive Officer
March 11, 2011
 
/s/ David L. Lowrance
David L. Lowrance
Vice President and Chief Financial Officer
March 11, 2011